FDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans
Metadata
Show full item recordCitation
FDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans (2003 Third Year Paper)Abstract
This paper is a description of tissue-engineered products, their potential for replacing conventional approaches to missing or failing tissues and organs, and FDA’s ongoing efforts to develop a comprehensive and uniform scheme for regulating them.Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965598
Collections
- HLS Student Papers [498]
Contact administrator regarding this item (to report mistakes or request changes)